Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a well-known complication following kidney transplantation (KT) that entails the uncontrolled proliferation of lymphoid cells. Extra-nodal involvement, including the central nervous system (CNS), can occur and is associated with poor survival, although outcomes may be improving over time. We present a fatal case of a recipient who developed CNS-PTLD. We then provide a brief overview of the disease incidence, the clinical presentation, risk factors, diagnostic and therapeutic approaches, outcomes, and prognosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Francis A, Johnson DW, Teixeira-Pinto A, Craig JC, Wong G. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study. Nephrol Dial Transplant. 2018;33(5):881–9.
Evens AM, Choquet S, Kroll-Desrosiers AR, et al. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant. 2013;13(6):1512–22.
Velvet AJJ, Bhutani S, Papachristos S, et al. A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature. Oncotarget. 2019;10(4):437–48.
Taj MM, Maecker-Kolhoff B, Ling R, et al. Primary post-transplant lymphoproliferative disorder of the central nervous system: characteristics, management, and outcome in 25 paediatric patients. Br J Haematol. 2021;193(6):1178–84.
Fox CP, Phillips EH, Smith J, et al. Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma. Br J Haematol. 2019;184(3):348–63.
Zimmermann H, Nitsche M, Pott C, et al. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry. Ann Hematol. 2021;100(8):2043–50.
Boyle S, Tobin JWD, Perram J, et al. Management and outcomes of diffuse large B-cell lymphoma post-transplant lymphoproliferative disorder in the era of PET and rituximab: a multicenter study from the Australasian lymphoma Alliance. Hema. 2021;5(11):e648.
Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016;2:15088.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.
Trappe R, Oertel S, Leblond V, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012;13(2):196–206.
Cavaliere R, Petroni G, Lopes MB, Schiff D. Primary central nervous system post-transplantation lymphoproliferative disorder: an international primary central nervous system lymphoma collaborative group report. Cancer. 2010;116(4):863–70.
Dugan JP, Haverkos BM, Villagomez L, et al. Complete and durable responses in primary central nervous system Posttransplant lymphoproliferative disorder with zidovudine, ganciclovir, rituximab, and dexamethasone. Clin Cancer Res. 2018;24(14):3273–81.
Anastasiou M, Mamez AC, Masouridi S, et al. Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximab. BMJ Case Rep. 2021;14(8)
Acknowledgments
None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fadel, E., Sandal, S. (2022). Central Nervous System Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_49
Download citation
DOI: https://doi.org/10.1007/978-3-031-13569-9_49
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13568-2
Online ISBN: 978-3-031-13569-9
eBook Packages: MedicineMedicine (R0)